Form 8-K · Current Report · Filed 2026-08-12
Cencora Announces Walgreens Volume Movement and Reaffirms Fiscal 2026 Guidance
Cencora, Inc. announced that beginning July 1, 2026, certain Walgreens volume that was being serviced by the company separate from the prime vendor agreement began moving outside the company. This operational change was fully contemplated in Cencora's August 5, 2026 commentary on fourth quarter expectations for its U.S. Healthcare Solutions segment. The company is reaffirming its previously issued adjusted diluted EPS guidance range of $17.75 to $17.95 for fiscal year 2026.
- Filer
- Cencora Inc. COR · NYSE
- Filed
- Accession
- 0001104659-26-094676
- CIK
- 0001140859
- Signal
- Medium impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Reported Item
Market reaction
Close before filing
$333.89
Since filing
+0.0%
Latest close
$333.89
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from COR reporting the same item, with the next session's move:
Insider tape
Within 45 days of this filing, COR insiders reported 6 Form 4 transactions — net buying of $122K.
About Cencora Inc.
Cencora Inc., formerly known as AmerisourceBergen Corporation, represents a pivotal entity in the global healthcare distribution and services sector. As a leading pharmaceutical sourcing and distribution services company, Cencora Inc. plays a critical role in ensuring the efficient supply of pharmaceutical products to a range of healthcare providers, including hospitals, pharmacies, and clinics. Its business model is centered on the seamless integration of logistics, consulting services, and the provision of innovative solutions aimed at improving pharmaceutical supply chain operations. Cencora Inc. impacts various segments of the healthcare industry by enhancing the availability and accessibility of healthcare products. Known for its global reach and extensive network of distribution centers, the company supports the delivery of critical medications and healthcare products across numerous geographies. Cencora Inc.'s significance in the market is underscored by its ability to partner with pharmaceutical manufacturers and healthcare providers to streamline processes, reduce costs, and improve patient outcomes. Headquartered in Conshohocken, Pennsylvania, Cencora Inc. remains a cornerstone of the healthcare distribution market, focusing on sustainability, innovation, and strategic collaborations.
Never miss another COR filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.